Edgewise Therapeutics Inc (NASDAQ: EWTX) on Tuesday, plunged -1.20% from the previous trading day, before settling in for the closing price of $29.98. Within the past 52 weeks, EWTX’s price has moved between $9.00 and $38.12.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 5.36%. With a float of $62.41 million, this company’s outstanding shares have now reached $94.41 million.
In an organization with 88 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 29.31%, operating margin of -6534.37%, and the pretax margin is -5519.27%.
Edgewise Therapeutics Inc (EWTX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Edgewise Therapeutics Inc is 34.09%, while institutional ownership is 74.06%. The most recent insider transaction that took place on Sep 20 ’24, was worth 2,120,101. In this transaction Chief Scientific Officer of this company sold 75,000 shares at a rate of $28.27, taking the stock ownership to the 12,719 shares. Before that another transaction happened on Sep 20 ’24, when Company’s General Counsel sold 50,000 for $28.37, making the entire transaction worth $1,418,510. This insider now owns 3,252 shares in total.
Edgewise Therapeutics Inc (EWTX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.36% per share during the next fiscal year.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Trading Performance Indicators
Edgewise Therapeutics Inc (EWTX) is currently performing well based on its current performance indicators. A quick ratio of 26.35 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.49, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.83 in one year’s time.
Technical Analysis of Edgewise Therapeutics Inc (EWTX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.87 million. That was inferior than the volume of 0.94 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 36.78%. Additionally, its Average True Range was 2.09.
During the past 100 days, Edgewise Therapeutics Inc’s (EWTX) raw stochastic average was set at 63.20%, which indicates a significant increase from 30.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 92.11% in the past 14 days, which was lower than the 92.43% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $32.72, while its 200-day Moving Average is $22.59. However, in the short run, Edgewise Therapeutics Inc’s stock first resistance to watch stands at $30.23. Second resistance stands at $30.83. The third major resistance level sits at $31.44. If the price goes on to break the first support level at $29.01, it is likely to go to the next support level at $28.40. Assuming the price breaks the second support level, the third support level stands at $27.80.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Key Stats
Market capitalization of the company is 2.80 billion based on 94,689K outstanding shares. Right now, sales total 0 K and income totals -100,160 K. The company made 0 K in profit during its latest quarter, and -34,130 K in sales during its previous quarter.
